Jacob A. Udell, MD, MPH

Original Contribution

Preoperative Intraaortic Balloon Pump Improves Early Outcomes Following High-Risk Coronary Artery Bypass Graft Surgery: A Meta-Analysis of Randomized Trials and Prospective Study Design

09/15/2017

Maral Ouzounian , MD, PhD;

Vladimír Dzavík , MD, FRCPC, FSCAI;

Penelope P. Rampersad , MD, MSc;

Rami Zawi , MD;

Christopher B. Overgaard , MD, MSc;

Michael E. Farkouh , MD, MSc;

Vinoda Sharma , MD;

Jacob A. Udell , MD, MPH;

Vivek Rao , MD, PhD;

Despite widespread use, evidence to support preemptive IABP insertion for patients undergoing high-risk CABG surgery remains sparse, and in need of a well-defined clinical trial. To inform the design of a prospective trial, we sought to...

Despite widespread use, evidence...

09/15/2017

Journal of Invasive Cardiology

Original Contribution

Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents – A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

09/15/2016

Jacob A. Udell , MD, MPH;

Shaun G. Goodman , MD, MSc;

Asim N. Cheema , MD, PhD;

Akshay Bagai , MD, MHS;

Anthony W.A. Wassef , MD;

Hadi Khafaji ;

Ishba Syed ;

Andrew T. Yan , MD;

Current guidelines recommend 12 months of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. We investigate whether the duration of DAPT can be safely shortened with use...

Current guidelines recommend 12...

09/15/2016

Journal of Invasive Cardiology